Mogamulizumab cuts infected cells in HTLV-1 myelopathy
(HealthDay)—For patients with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy-tropical spastic paraparesis (HAM-TSP), treatment with the humanized anti-CCR4 monoclonal antibody that targets infected cells, ...
Feb 8, 2018
0
6